Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Johnson & Johnson    JNJ   US4781601046

JOHNSON & JOHNSON (JNJ)

188
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 

Johnson & Johnson : FDA : J&J Unit Recalls Potentially Flammable Bone Putty

08/21/2012 | 06:13pm US/Eastern
Recommend:
0
   By Ben Fox Rubin 
 

The Food and Drug Administration said Johnson & Johnson (JNJ) unit Synthes last month initiated a recall on certain lots of bone putty, saying the medical product could catch fire during surgery.

The FDA gave the recall a Class I designation, its most serious type of recall.

The regulator said Synthes in early July issued a medical device recall letter, asking medical facilities to examine their inventories and immediately stop using specific lots of the putty. The product, called a hemostatic bone putty, is used to stop bone bleeding by creating a physical barrier along the edges of bones that have been damaged by trauma or cut during surgery.

The FDA said the putty could ignite under some conditions if contacted with certain surgical equipment.

The lots recalled were manufactured between July 6, 2011, and Dec. 14, 2011, and were distributed from Dec. 22, 2011, to June 25, 2012.

J&J in June completed its $19.7 billion purchase of medical-device maker Synthes. The health-care giant has worked to tackle a range of problem products, such as the bottles of children's Tylenol and other popular over-the-counter medicines, as well as some contact lenses and certain hip implants, that the company recalled due to manufacturing problems.

The company's shares closed Tuesday at $67.78 and were up 15 cents after hours. The stock is up 3.4% so far this year.

Write to Ben Fox Rubin at ben.rubin@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Recommend :
0
React to this article
Latest news on JOHNSON & JOHNSON
2h ago Zimmer to buy Biomet for $13.35 billion in latest consolidation
3h ago JOHNSON & JOHNSON : Arkansas court won't reconsider Risperdal case
3h ago JOHNSON & JOHNSON : J&J: Business doing well on new product approvals
5h ago JOHNSON & JOHNSON : Announces Dividend Increase of 6.1%
9h ago JOHNSON & JOHNSON : Federal Court to Hear Arguments in Challenge to Oregon Marri..
12h ago JOHNSON & JOHNSON : Risperdal Breast-Growth Lawyer Help: Resource4thePeople Enco..
1d ago JOHNSON & JOHNSON : Researchers at Johnson & Johnson Have Reported New Data on H..
1d ago JOHNSON & JOHNSON : Kelly Rutherford and Nigel Barker Join Global Moms Relay Par..
1d ago JOHNSON & JOHNSON : to Host Medical Devices & Diagnostics Business Review
1d ago JOHNSON & JOHNSON : Solar power surging in Latin America with World Cup fever
Advertisement
Chart
Duration : Period :
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | 4-Traders
Income Statement Evolution
Johnson _ Johnson : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF